Avadel Pharmaceuticals (AVDL) News Today $12.02 -1.13 (-8.59%) (As of 11/13/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Avadel Pharmaceuticals (NASDAQ:AVDL) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPSAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) released its quarterly earnings data on Tuesday. The company reported ($0.03) EPS for the quarter, beating analysts' consensus estimates of ($0.06) by $0.03. Avadel Pharmaceuticals had a negative net margin of 111.64% and a negative return on equity of 122.64%. The company had revenue of $50.00 million during the quarter, compared to analyst estimates of $48.43 million. During the same period last year, the business earned ($0.41) earnings per share. Avadel Pharmaceuticals's revenue was up 624.6% compared to the same quarter last year.November 13 at 10:23 AM | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.9% on Analyst DowngradeAvadel Pharmaceuticals (NASDAQ:AVDL) Trading Down 3.9% Following Analyst DowngradeNovember 13 at 10:16 AM | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Lowered to $25.00 at HC WainwrightHC Wainwright reduced their price target on shares of Avadel Pharmaceuticals from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Wednesday.November 13 at 8:42 AM | marketbeat.comAvadel Pharmaceuticals to Present at the Jefferies London Healthcare ConferenceNovember 13 at 8:00 AM | globenewswire.comAvadel Pharmaceuticals plc (AVDL) Q3 2024 Earnings Call TranscriptNovember 12 at 4:09 PM | seekingalpha.comAvadel Pharmaceuticals' (AVDL) Buy Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $22.00 price objective on shares of Avadel Pharmaceuticals in a research note on Tuesday.November 12 at 8:48 AM | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives $24.71 Average Target Price from AnalystsNovember 12 at 4:47 AM | americanbankingnews.comAvadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 11 at 10:29 AM | finance.yahoo.comAvadel Pharmaceuticals (AVDL) Scheduled to Post Earnings on TuesdayNovember 10 at 3:52 AM | americanbankingnews.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Recommendation of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been given an average recommendation of "Buy" by the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price objectiveNovember 7, 2024 | marketbeat.comAvadel Pharmaceuticals (AVDL) Scheduled to Post Quarterly Earnings on TuesdayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comAvadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12November 4, 2024 | finance.yahoo.comAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $30.00 at OppenheimerNovember 3, 2024 | americanbankingnews.comLoss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-TermNovember 1, 2024 | finance.yahoo.comAvadel Pharmaceuticals (NASDAQ:AVDL) Stock, Insider Trading ActivityNovember 1, 2024 | benzinga.comAvadel announces favorable ruling in admin procedure act litigationOctober 31, 2024 | markets.businessinsider.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from HC WainwrightHC Wainwright reissued a "buy" rating and set a $27.00 price target on shares of Avadel Pharmaceuticals in a report on Thursday.October 31, 2024 | marketbeat.comAvadel Pharma Shares Rise on Favorable Ruling for FDA in Lumryz LitigationOctober 31, 2024 | marketwatch.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Should You Buy?Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up - Here's WhyOctober 31, 2024 | marketbeat.comIridian Asset Management LLC CT Purchases 50,000 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Iridian Asset Management LLC CT lifted its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 42.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 167,700 shares of the company's stock after purchasing an additionaOctober 31, 2024 | marketbeat.comAvadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act LitigationOctober 31, 2024 | globenewswire.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest UpdateAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totalling 10,190,000 shares, a decrease of 7.1% from the September 30th total of 10,970,000 shares. Based on an average daily volume of 889,600 shares, the short-interest ratio is presently 11.5 days.October 30, 2024 | marketbeat.comAvadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep AdvancesOctober 24, 2024 | markets.businessinsider.comAvadel Pharmaceuticals, nference announce publication on sleep advancesOctober 24, 2024 | markets.businessinsider.comAvadel Pharmaceuticals: Buoyant Outlook with LUMRYZ Approval and Legal ResolutionsOctober 21, 2024 | markets.businessinsider.comAvadel Pharmaceuticals' (AVDL) Buy Rating Reiterated at HC WainwrightHC Wainwright reiterated a "buy" rating and set a $27.00 price target on shares of Avadel Pharmaceuticals in a report on Monday.October 21, 2024 | marketbeat.comClaro Advisors LLC Has $644,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Claro Advisors LLC increased its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 379.2% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 49,080 shares of the company's stock after acquiring an additionOctober 20, 2024 | marketbeat.comCraig-Hallum Remains a Buy on Avadel Pharmaceuticals (AVDL)October 19, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Avadel Pharmaceuticals (AVDL), Rani Therapeutics Holdings (RANI)October 19, 2024 | markets.businessinsider.comAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reaffirmed at Needham & Company LLCNeedham & Company LLC restated a "buy" rating and set a $22.00 target price on shares of Avadel Pharmaceuticals in a research report on Friday.October 18, 2024 | marketbeat.comUS FDA expands use of Avadel's sleep disorder drug to ages 7 and upOctober 18, 2024 | reuters.comAvadel Gets Expanded FDA OK of Lumryz for Use in ChildrenOctober 17, 2024 | marketwatch.comAvadel Pharma's SNDA For Lumryz Gets FDA ApprovalOctober 17, 2024 | markets.businessinsider.comAvadel Pharmaceuticals Announces FDA Approval of LUMRYZ™ (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with NarcolepsyOctober 17, 2024 | globenewswire.comShort Interest in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Decreases By 5.9%Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw a large decrease in short interest in the month of September. As of September 30th, there was short interest totalling 10,970,000 shares, a decrease of 5.9% from the September 15th total of 11,660,000 shares. Based on an average daily trading volume, of 927,500 shares, the short-interest ratio is presently 11.8 days.October 16, 2024 | marketbeat.comThe Manufacturers Life Insurance Company Invests $590,000 in Avadel Pharmaceuticals plc (NASDAQ:AVDL)The Manufacturers Life Insurance Company bought a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 41,979 shares of the company's stock, valueOctober 16, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Rating of "Buy" by AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been given an average rating of "Buy" by the seven research firms that are currently covering the firm, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month target price aOctober 13, 2024 | marketbeat.comAvadel Pharmaceuticals PLC (AVDL) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...October 9, 2024 | finance.yahoo.comAvadel Pharmaceuticals (NASDAQ:AVDL) Stock, Short Interest ReportOctober 9, 2024 | benzinga.comAvadel Pharmaceuticals (NASDAQ:AVDL) Stock Quotes, Forecast and News SummaryOctober 9, 2024 | benzinga.comRenaissance Technologies LLC Has $905,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Renaissance Technologies LLC trimmed its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 84.1% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,396 shares of the companyOctober 8, 2024 | marketbeat.comNantahala Capital Management LLC Invests $4.92 Million in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Nantahala Capital Management LLC purchased a new position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 350,000 shares of the company's stock, vOctober 1, 2024 | marketbeat.comTroluce Capital Advisors LLC Makes New Investment in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Troluce Capital Advisors LLC bought a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 150,000 shares of the company's stock, valued at approximately $September 25, 2024 | marketbeat.comAlly Bridge Group NY LLC Sells 116,791 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Ally Bridge Group NY LLC decreased its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 21.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 430,245 shares of the company's stoSeptember 23, 2024 | marketbeat.comRhumbline Advisers Purchases 121,130 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Rhumbline Advisers grew its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 7,840.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 122,675 shares of the companSeptember 21, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Rating of "Buy" by BrokeragesAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been assigned an average recommendation of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month target pricSeptember 18, 2024 | marketbeat.comBank of New York Mellon Corp Acquires New Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Bank of New York Mellon Corp acquired a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 325,388 shares of the company's stock, valued at approximately $4,575,0September 14, 2024 | marketbeat.comAvadel Pharma says its sleep disorder drug remains under FDA reviewSeptember 13, 2024 | reuters.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 4.9% Avadel Pharmaceuticals (NASDAQ:AVDL) Trading Down 4.9%September 11, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Rating Reiterated by Needham & Company LLCNeedham & Company LLC reaffirmed a "buy" rating and set a $22.00 target price on shares of Avadel Pharmaceuticals in a research note on Wednesday.September 4, 2024 | marketbeat.com Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Top "Sleeping Giant" Crypto In The Market Now (Ad)Top "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your financial future. Click here to discover our #1 crypto pick before it's too late AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.890.55▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼154▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCYC News Today COLL News Today IMUX News Today OVID News Today NUVL News Today ACLX News Today ADMA News Today KRYS News Today RNA News Today BBIO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
